๐ฐ Data Management News
Page 148 - Data Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Data Management. Real-time updates on events, politics, business and more.
June 8, 2023
A healthcare company on a mission to produce a multi-cancer early detection (MCED) test so patients have more chance of being cured, has produced 'exciting results' from a study.
June 7, 2023
SimCorp widens partnership with Baloise June 7, 2023 SimCorp announces that it has expanded its long-standing partnership with Baloise Asset... | June 7, 2023
June 7, 2023
With generative AI continuing to create a buzz, OSP took the opportunity to speak to Indegene, a digital-first, life sciences commercialization company that helps biopharmaceutical, emerging biotech and medical device companies develop products. Talking to Tarun Mathur and Sameer Lal, we found out how they thought AI could change the life sciences landscape.
June 7, 2023
Scale AI workloads, for all your data, anywhere, with watsonx.data.
June 7, 2023
Domasi Institute of Management and Technology held its first ever graduation in Zomba where 59 students were awarded with diplomas with a call to pursue
June 6, 2023
In the wake of the Ion hack, regulators are pushing for firms to beef up their cyber defenses. Anthony says that they'll need to mind their words and tread
June 6, 2023
Enterprises accelerating AI Innovation in the MENA region
June 6, 2023
The continent features prominently in global top 100 for online threats, with Kenya ranked 35th, Nigeria 50th and South Africa 82nd.
June 6, 2023
Ikon Science, a leading global provider of geoprediction and open subsurface knowledge management software and services, today announced the release of Curate 2023.3. Curate is a cloud-native subsurface knowledge management solution that unlocks siloed data enabling users to make well-informed decisions with increased confidence and expedite workflows.
June 6, 2023
'Compelling and landmark' results will โfundamentally changeโ the journey of patients with stage 2 and 3 early breast cancer, specifically those in need of new, well-tolerated options to prevent their cancer from coming back.